Major response to sunitinib (Sutene®) in metastatic malignant phyllodes tumor of breast
- 176 Downloads
KeywordsPaclitaxel Renal Cell Carcinoma Sunitinib Chondrosarcoma Chest Compute Tomography
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This study was supported by NCC grant No. 0610240-3.
- 2.Reinfuss M, Mitus J, Duda K et al (1996) The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 77:910–916 doi: 10.1002/(SICI)1097-0142(19960301)77:5<910::AID-CNCR16>3.0.CO;2-6 PubMedCrossRefGoogle Scholar
- 5.Mendel DB, Laird AD, Xin X et al (2003) In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res 9:327–337PubMedGoogle Scholar
© Springer Science+Business Media, LLC 2008